BIIB105
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BIIB105, covering 2025-10-09 to 2025-10-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation [Phase 1, Phase 2]